| |
| |
|
| Insider
Information: |
Wiezorek Jeffrey |
| Relationship: |
SVP Clinical Development |
| City: |
Santa Monica |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kite Pharma, Inc. |
KITE |
SVP Clinical Development |
2017-10-03 |
0 |
2015-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2017-03-01 |
4 |
AS |
$68.92 |
$1,350,144 |
D/D |
(18,000) |
21,071 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2017-03-01 |
4 |
OE |
$6.89 |
$124,020 |
D/D |
18,000 |
39,071 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2017-10-03 |
4 |
D |
$180.00 |
$2,641,320 |
D/D |
(14,674) |
11,150 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,150) |
0 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2017-07-03 |
4 |
OE |
$6.89 |
$68,900 |
D/D |
10,000 |
31,071 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2017-07-03 |
4 |
AS |
$104.26 |
$1,043,201 |
D/D |
(10,000) |
21,071 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2017-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,107 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
VP Clinical Development |
• – – |
2015-05-15 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
10,218 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
VP Clinical Development |
• – – |
2015-05-15 |
4 |
AS |
$49.44 |
$451,339 |
D/D |
(9,000) |
1,218 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
VP Clinical Development |
• – – |
2015-06-15 |
4 |
AS |
$55.93 |
$513,031 |
D/D |
(9,000) |
5,218 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
VP Clinical Development |
• – – |
2015-06-15 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
14,218 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
VP Clinical Development |
• – – |
2015-07-15 |
4 |
AS |
$70.12 |
$647,257 |
D/D |
(9,000) |
5,218 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
VP Clinical Development |
• – – |
2015-07-15 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
14,218 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
VP Clinical Development |
• – – |
2015-08-17 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
14,218 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
VP Clinical Development |
• – – |
2015-08-17 |
4 |
AS |
$60.26 |
$547,820 |
D/D |
(9,000) |
5,218 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
VP Clinical Development |
• – – |
2015-09-15 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
15,342 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
VP Clinical Development |
• – – |
2015-09-15 |
4 |
AS |
$63.99 |
$579,018 |
D/D |
(9,000) |
6,342 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2015-10-15 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
15,342 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2015-10-15 |
4 |
AS |
$60.42 |
$563,319 |
D/D |
(9,000) |
6,342 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2015-11-16 |
4 |
AS |
$76.43 |
$702,681 |
D/D |
(9,000) |
6,342 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2015-11-16 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
15,342 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2015-12-15 |
4 |
AS |
$62.64 |
$573,989 |
D/D |
(9,000) |
6,342 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2015-12-15 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
15,342 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2016-01-15 |
4 |
AS |
$52.60 |
$497,379 |
D/D |
(9,000) |
13,742 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
SVP Clinical Development |
• – – |
2016-01-15 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
22,742 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
